Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jet-Alert
- Development stage
- Unknown
- Lead developer
- Bell Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Jet-Alert is an over-the-counter (OTC) central nervous system stimulant manufactured by Bell Pharmaceuticals. Its active ingredient is caffeine, a small molecule methylxanthine that helps restore mental alertness or wakefulness in individuals experiencing occasional fatigue or drowsiness. The product is available in two oral formulations: Regular Strength, containing 100 mg of caffeine per tablet, and Double Strength, containing 200 mg per caplet. Caffeine works primarily by antagonizing adenosine receptors in the brain, thereby inhibiting the sleep-promoting effects of endogenous adenosine. It is intended for use in adults and children 12 years of age and older and is marketed as a non-habit-forming, fast-acting aid for temporary alertness.
- Brand names
- Jet-Alert
- Other names
- caffeine
02
Targets
ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)
Beyond the preview
Go deeper on Jet-Alert.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jet-Alert.